YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

SLP
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

seekingalpha.comPOSITIVO

Simulations Plus expands FDA partnership with ADMET predictor software deal

* Simulations Plus (SLP [https://seekingalpha.com/symbol/SLP]) Thursday said [https://seekingalpha.com/pr/20656219-simulations-plus-expands-fda-adoption-of-admet-predictor-with-new-licenses-for-the-cosmetics]that the U.S. Food and Drug Adm…

finance.yahoo.comPOSITIVO

Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch

Agency will use the software platform to support modern cosmetic safety assessment through integrated exposure and toxicity modeling. RESEARCH TRIANGLE PARK, N.C., September 17, 2026--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (…

globenewswire.comNEUTRAL

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

SAN DIEGO, July 24, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. O…

globenewswire.comPOSITIVO

Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…

nasdaq.comNEGATIVO

Simulation Plus Q3 Returns To Profit, Revenues Rise

(RTTNews) - On Friday, Simulation Plus, Inc. (SLP), a provider of AI-enabled drug development software, reported a profit in the third quarter of 2026 from a loss last year, mainly due to the absence of prior year's impairment charges and…

nasdaq.comPOSITIVO

Stocks Climb on Strength in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is up +0.47%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.55%. September E-mini S&P futures (ESU26) are up +0.47%, and September E-mini N…

finance.yahoo.comPOSITIVO

Stocks Climb on Strength in Chipmakers

The S&P 500 Index ($SPX) (SPY) today is up +0.47%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.55%. September E-mini S&P futures (ESU26) are up +0.47%, and September E-mini N…

nasdaq.comNEGATIVO

Stocks Weighed Down by Geopolitical Risks

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.27%. September E-mini S&P futures (ESU26) fell -0.35%, a…

seekingalpha.comNEGATIVO

Simulations Plus Q3 2026 Earnings Preview

* Simulations Plus (SLP [https://seekingalpha.com/symbol/SLP]) is scheduled to announce Q3 earnings results on Thursday, July 9th, after market close. * The consensus EPS Estimate is $0.23 [https://seekingalpha.com/symbol/SLP/earnings/esti…

finance.yahoo.comNEGATIVO

Stocks Weighed Down by Geopolitical Risks

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.27%. September E-mini S&P futures (ESU26) fell -0.35%, a…

globenewswire.comPOSITIVO

Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…

globenewswire.comNEUTRAL

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. O…

globenewswire.comPOSITIVO

Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

SAN DIEGO, June 29, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation concerns whether Simulations Plus or c…

finance.yahoo.comPOSITIVO

[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global In Silico Clinical Trials Market size & share revenue was valued at approximately USD…

globenewswire.comPOSITIVO

Halper Sadeh LLC is Investigating Whether ALOT, SLP, OLN are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…

finance.yahoo.comPOSITIVO

Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

New capabilities connect AI agents, scientific literature, and validated computational engines to accelerate model-informed drug development RESEARCH TRIANGLE PARK, N.C., June 23, 2026--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP)…

finance.yahoo.comPOSITIVO

Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Certara's updated analyst model now carries a slightly lower fair value price target of US$7.48, compared with the prior US$7.62, r…

finance.yahoo.comPOSITIVO

Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls

Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by T…

finance.yahoo.comPOSITIVO

Altaris to acquire Simulations Plus in $375m all-cash deal

Simulations Plus has entered a definitive agreement to be purchased by affiliates of Altaris in an all-cash transaction valued at approximately $375m. Under the deal, Simulations Plus shareholders will receive $18.50 per share, representin…

nasdaq.comPOSITIVO

Top Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212

(RTTNews) - Tuesday's top gainers include CervoMed, with key clinical trial catalysts ahead; Conexeu, which strengthened its leadership with board expansion; NeOnc, advancing its lead drug candidate into Phase 2 for aggressive brain tumour…

globenewswire.comPOSITIVO

Halper Sadeh LLC is Investigating Whether SLP, ROKU, TBRG are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…

seekingalpha.comPOSITIVO

Altaris to Acquire Simulations Plus for $375M

Simulations Plus (SLP [https://seekingalpha.com/symbol/SLP]) has entered into a definitive agreement to be acquired by affiliates of Altaris for $375 in an all-cash transaction. Under the terms of the agreement, Simulations Plus common sto…

globenewswire.comPOSITIVO

Robbins LLP Reminds SLP Stockholders of its Investigation into Simulation Plus, Inc.; Contact the Firm for Information

SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws and brea…

globenewswire.comPOSITIVO

SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws and brea…

finance.yahoo.comPOSITIVO

NVIDIA (NVDA): The Best Quality Stock to Buy and Hold for the Next 5 Years

NVIDIA Corporation (NASDAQ:NVDA) is one of the 10 Best Quality Stocks to Buy and Hold for the Next 5 Years. On May 6, 2026, Simulations Plus announced a technical collaboration with NVIDIA Corporation (NASDAQ:NVDA) focused on enabling GPU-…

finance.yahoo.comPOSITIVO

PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump

PTC Inc. PTC reported second-quarter fiscal 2026 non-GAAP earnings of $2.69 per share, which jumped 50% year over year and beat the Zacks Consensus Estimate by 30.6%. Management had estimated non-GAAP EPS in the range of $1.87 to $2.47. Qu…

finance.yahoo.comPOSITIVO

Cadence Q1 Earnings Top Estimates, 2026 Revenue Outlook Raised

Cadence Design Systems CDNS delivered a strong first quarter of 2026, driven by broad-based demand for its AI-oriented portfolio amid robust design activity. Non-GAAP earnings per share (EPS) of $1.96 beat the Zacks Consensus Estimate by 4…

finance.yahoo.comPOSITIVO

Iridium's Q1 Earnings Miss Estimates, Revenues Increase Y/Y

Iridium Communications IRDM reported earnings per share (EPS) of 20 cents for the first quarter of 2026, missing the Zacks Consensus Estimate by 25.9%. The bottom line also compared unfavorably with the prior-year quarter's figure of 27 ce…

finance.yahoo.comPOSITIVO

SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Momentum & AI Tailwinds

SAP SE SAP reported first-quarter 2026 non-IFRS earnings per share (EPS) of €1.72 ($2.01), which increased 20% from the year-ago quarter. The Zacks Consensus Estimate was pegged at $1.92. Driven by momentum in the cloud business, SAP repor…

finance.yahoo.comPOSITIVO

Biosimulation Market Research and Global Forecast Report 2026-2036: Expansion Driven by Precision Medicine, AI-Powered In-Silico Drug Development and Rising Demand for Cost-Efficient Clinical Trials

Company Logo The global biosimulation market is projected to surge from USD 6.15 billion in 2026 to USD 28.50 billion by 2036, reflecting a CAGR of 16.5%, according to the report "Biosimulation Market - Global Forecast to 2036". Key growth…

finance.yahoo.comPOSITIVO

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making RESEARCH TRIANGLE PARK, N.C., Ap…

finance.yahoo.comPOSITIVO

Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips

Badger Meter, Inc. BMI reported earnings per share (EPS) of 93 cents for first-quarter 2026, which missed the Zacks Consensus Estimate by 22.5%. The bottom line compared unfavorably with the year-ago quarter’s EPS of $1.30. Quarterly net s…

finance.yahoo.comPOSITIVO

Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development

Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced collaboration programs for AI-enabled modeling in drug development. Simulations Plus uses AI to help scientists incre…

finance.yahoo.comPOSITIVO

Morning Movers: Organon jumps after report of Sun Pharmaceutical bid

Stock futures are essentially flat, reflecting a market waiting for confirmation. Markets are ending the week in a cautious holding pattern, with momentum from earlier in the week fading. Easter Sale - 70% Off TipRanks Unlock hedge fund-le…

nasdaq.comPOSITIVO

Why Simulations Plus Stock Inched Higher Today

Key Points It notched beats on both revenue and profitability in its fiscal second quarter. On a negative note, it cut its net income forecast for the full fiscal year.10 stocks we like better than Simulations Plus › Medical tech company S…

finance.yahoo.comPOSITIVO

Why Simulations Plus Stock Inched Higher Today

Medical tech company Simulations Plus(NASDAQ: SLP) ended up slightly in positive territory on Friday. That was largely due to solid quarterly results, although a bottom-line guidance cut dampened some investors' enthusiasm. Ultimately, the…